Home » All » Stock Forecast » Cullinan Therapeutics Inc. Common Stock Forecast

Cullinan Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -2.07%Market Cap $860.68M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$14.07 ▼ -1.06%	Yesterday	$14.28 ▲ +0.45%	Tomorrow's Cullinan Therapeutics Inc. Common Stock (CGEM) setup is anchored to $14.22 and targets $14.07 (-1.06%). The near-term read is downside; watch $14.65 / $13.79 because daily realized volatility is about 5.47%.
Tomorrow's Cullinan Therapeutics Inc. Common Stock (CGEM) setup is anchored to $14.22 and targets $14.07 (-1.06%). The near-term read is downside; watch $14.65 / $13.79 because daily realized volatility is about 5.47%.
Week	$13.75 ▼ -3.30%	Last Week	$14.42 ▲ +1.39%	The 7-day Cullinan Therapeutics Inc. Common Stock model moves from $14.42 to $13.75 (-3.30%). It gives downside momentum context for this stock, so breaks around $14.65 / $13.79 matter more than a single tick.
The 7-day Cullinan Therapeutics Inc. Common Stock model moves from $14.42 to $13.75 (-3.30%). It gives downside momentum context for this stock, so breaks around $14.65 / $13.79 matter more than a single tick.
Month	$13.22 ▼ -7.03%	Last Month	$14.64 ▲ +2.95%	The 1-month Cullinan Therapeutics Inc. Common Stock target is $13.22 (-7.03%), compared with the live reference near $14.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Cullinan Therapeutics Inc. Common Stock target is $13.22 (-7.03%), compared with the live reference near $14.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$12.43 ▼ -12.62%	Last Year	$14.97 ▲ +5.30%	The 1-year Cullinan Therapeutics Inc. Common Stock scenario points to $12.43 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Cullinan Therapeutics Inc. Common Stock scenario points to $12.43 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$10.56 ▼ -25.71%	5 Years Ago	$15.76 ▲ +10.80%	The 5-year Cullinan Therapeutics Inc. Common Stock view is $10.56 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Cullinan Therapeutics Inc. Common Stock view is $10.56 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$14.07▼ -1.06%

Yesterday$14.28▲ +0.45%

Tomorrow's Cullinan Therapeutics Inc. Common Stock (CGEM) setup is anchored to $14.22 and targets $14.07 (-1.06%). The near-term read is downside; watch $14.65 / $13.79 because daily realized volatility is about 5.47%.

Week$13.75▼ -3.30%

Last Week$14.42▲ +1.39%

The 7-day Cullinan Therapeutics Inc. Common Stock model moves from $14.42 to $13.75 (-3.30%). It gives downside momentum context for this stock, so breaks around $14.65 / $13.79 matter more than a single tick.

Month$13.22▼ -7.03%

Last Month$14.64▲ +2.95%

The 1-month Cullinan Therapeutics Inc. Common Stock target is $13.22 (-7.03%), compared with the live reference near $14.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$12.43▼ -12.62%

Last Year$14.97▲ +5.30%

The 1-year Cullinan Therapeutics Inc. Common Stock scenario points to $12.43 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$10.56▼ -25.71%

5 Years Ago$15.76▲ +10.80%

The 5-year Cullinan Therapeutics Inc. Common Stock view is $10.56 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$14.22	Mid
Daily Change	-2.07%	Below
Volatility Cap	20.0%	Mid
Confidence	62%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$14.22

Daily Change-2.07%

Market Cap$860.68M

Sourcenasdaq-screener

Current	$14.22	Daily Change	-2.07%
Market Cap	$860.68M	Source	nasdaq-screener

Support & Resistance Levels

$13.79Support 1

$14.22Current

$14.65Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$14.22Live reference price

Used as the anchor for generated forecast calculations.

Next Month$13.22Model projection-7.03%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

62%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

62%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in CGEM today

Bullish Scenario

$14.93

+5.00% from current

Target Price$14.93

ScenarioUpside momentum

Probability54%

Base Scenario

$13.22

-7.03%

Target Price$13.22

ScenarioCapped drift

Probability62%

Bearish Scenario

$13.51

-5.00% from current

Target Price$13.51

ScenarioVolatility drawdown

Probability38%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 35/100

24H drift-1.06%

7D drift-3.30%

30D drift-7.03%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 27/100

1M outlook-7.03%

1Y outlook-12.62%

5Y outlook-25.71%

Frequently Asked Questions

Q What is the Cullinan Therapeutics Inc. Common Stock (CGEM) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Cullinan Therapeutics Inc. Common Stock is projected near $14.07 versus the current reference around $14.22. That implies a modeled move of -1.06% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for CGEM?

The weekly Cullinan Therapeutics Inc. Common Stock model points to $13.75, which maps to an expected drift of -3.30% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Cullinan Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Cullinan Therapeutics Inc. Common Stock 1-month target is $13.22 (-7.03%), while the 1-year target is $12.43 (-12.62%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Cullinan Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Cullinan Therapeutics Inc. Common Stock long-horizon scenario sits near $10.56 with a modeled change of -25.71%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are CGEM support and resistance zones right now?

For Cullinan Therapeutics Inc. Common Stock, nearest resistance is around $13.79, while nearest support is around $14.65. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Cullinan Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.